Mycophenolate mofetil

As per available reports about 48 journals, 26 Conferences, 31 workshops are presently dedicated exclusively to Mycophenolate mofetil and about 21458 articles are being published on the current trends in Mycophenolate mofetil. In terms of research annually, USA, India, Japan, Brazil and Canada are some of the leading countries where maximum studies related to Mycophenolate mofetil are being carried out. Mycophenolate-mofetil is used for the treatment of autoimmune diseases like Behçet's disease, pemphigus vulgaris, systemic lupus erythematosus and refractory incomplete lupus erythematosus.

 

Journal of Nephrology & Therapeutics is an Open Access journal and aims to publish most complete and reliable source of information on the discoveries and current developments in the mode of original articles, review articles, case reports, short communications, etc. in all areas of the field and making them freely available through online without any restrictions or any other subscriptions to researchers worldwide.

 

OMICS International – a pioneer in organizing international conferences on Mycophenolate mofetil

 

“4th International Conference on Nephrology and Therapeutics” which is scheduled to organize on May 04-06, 2015 at Baltimore, USA. The scientific program concentrates around the theme “Integrating recent discoveries and interpreting clinical research for better renal health.” The 4th International Conference on Nephrology & Therapeutics will discuss the latest technologies and therapeutic aspects developed for various kidney diseases which include renal transplantation, dialysis equipments and other procedures involved in treatment of Chronic Kidney Diseases and End Stage Renal Diseases.